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Abstract
Background: Dyslipidaemia is highly associated with cardiovascular and cerebrovascular diseases, which have been
ranked second and third place of leading causes of death in Taiwan. Some plant extracts have been proved
effective against dyslipidaemia. However, the combination of plant extracts was rarely studied. The purpose of the
present study is to understand the beneficial effects of a combined extract (comprising cocoa, coffee, green tea
and garcinia; CCGG) on lipid profiles in serum, liver, and faeces as well as glycaemic markers and related
proinflammatory cytokines by using an appropriate animal model, the golden Syrian hamster.
Methods: A total of 40 male hamsters were randomly assigned to five groups: (1) vehicle control, (2) high-cholesterol
diet control, (3) high-cholesterol diet of 311 mg/kg/d of CCGG, (4) high-cholesterol diet of 622 mg/kg/d of CCGG and
(5) high-cholesterol diet of 1555 mg/kg/d of CCGG. At the end of the experiment, blood, tissue and faecal samples
were collected for further analysis.
Results: After 6 weeks of treatment, CCGG supplementation significantly reduced serum lipid content (triglycerides,
total cholesterol and LDL-C) and hepatic lipid content (triglycerides and cholesterol) with dose-dependent effects. In
addition, an increase in excretion of faecal lipids (bile acids) was observed after supplementation. Furthermore, the
homeostasis model assessment of insulin resistance (HOMA-IR) index and serum proinflammatory cytokine levels
(TNF-α and IL-6) involved in dyslipidaemia was markedly improved. In addition, by monitoring biochemical parameters
as well as histopathology of major tissues, no toxicity was observed after the consumption of CCGG.
Conclusion: Dietary CCGG supplementation may exert potential effects on ameliorating hyperlipidaemia, insulin
resistance, liver steatosis and related inflammation.
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Background
As time has progressed and society advances, indulgent
lifestyles have produced “lifestyle diseases”, particularly
dyslipidaemia. Dyslipidaemia is a disease characterised by
an abnormal amount of lipids in the blood, which can re-
sult in a predisposition to coronary, cerebrovascular and
peripheral vascular arterial diseases. In addition, systemic
inflammation has been proposed to be accompanied by
dyslipidaemia, producing several proinflammatory factors
(including tumour necrosis factor (TNF)-α and interleukin
6 (IL-6)) [1, 2]. Since 2000, cardiovascular and cerebrovas-
cular diseases have been ranked second and third place of
leading causes of death in Taiwan. According to the
Industry & Technology Intelligence Service (Taiwan), dys-
lipidaemia prevalence has exceeded 10 % of the population
(older than 15 y) in Taiwan. Moreover, dyslipidaemia is
observed in the younger population. Dyslipidaemia se-
verely threatens health and is associated with exorbitant
medical expenses.
Current blood lipid-lowering drugs have a higher effi-
cacy and potency than before; however, some adverse
effects still occur when medication is taken. Minor
gastrointestinal complaints including nausea, cramping
and constipation occur when bile acid resins are taken [3].
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Niacin appears to cause cutaneous flushing and itching
[3]. Statins and fibric acids may be associated with in-
creased serum aminotransferase levels, creatine kinase
levels, myopathy and rhabdomyolysis [3]. Diet control and
increased physical activity are frequently encouraged to
ameliorate dyslipidaemia [3]. Studies [4–7] have revealed
that consuming plant or natural extract supplements is
beneficial. Plant polyphenols have recently gained increas-
ing attention because of their potent properties against
blood lipids and related inflammatory responses. Cocoa,
coffee, green tea and garcinia (CCGG) contain abundant
polyphenols, particularly proanthocyanidins, chlorogenic
acids, catechins and xanthones, respectively [8–11]. Poly-
phenols potentially reduce blood lipids and have an antiin-
flammatory effect [12–17].
Regarding to CCGG, there were some obvious evidences
for CCGG against dyslipidaemia stated in rodent and
in vitro studies. Nwichi et al. [18] demonstrated an 8-weeks
administration of cocoa extract exhibited hypolipidaemic
effects in cholesterol-fed rats. Song et al. [19] demon-
strated that an 11-week consumption of decaffeinated
green coffee bean significantly reduced plasma lipids in
high-fat diet fed mice. Yan et al. [20] studied the 6-weeks
effect of green tea polysaccharides and polyphenols in
high-fat diet fed rats, both of them showed effective reduc-
tion in serum lipids. Bumrungpert et al. [21] revealed the
effects of mangosteen against inflammation and insulin re-
sistance in human adipocytes. Despite of the fact that pre-
vious studies have stated the beneficial effects of diverse
polyphenol-rich extracts in isolation, very few studies have
examined the combination. However, combined ingredi-
ents may enhance the benefit and reduce the effective dose
[22], also exert a synergistic effect [23].
Since the early 1980s, an animal model, the golden
Syrian hamster, has been employed to assess diet-
induced atherosclerosis [24]. In general, using unmodi-
fied rats or mice as animal models is unsuitable for
examining diet-induced changes in blood lipids because
they do not develop aortic lesions or an atherogenic
lipoprotein profile (nHDL-C >HDL-C) similar to human
beings [25]. Hamsters are a more appropriate animal
model. Recently, numerous studies have adopted ham-
sters to investigate the effect of plant extracts on blood
lipids [5, 26, 27]. Therefore, in the present study, we ex-
amined the potential effects and dose-response relation-
ship of combined extract (composed of CCGG) on lipid
profiles, glycaemic markers and inflammatory responses
in hamsters. We monitored common toxicity markers
that may be influenced after the intake of CCGG.
Methods
Diets and chemicals
A commercially available supplement consisting of CCGG
(beans of Theobroma cacao, beans of Coffea robusta,
leaves of Camellia sinensis and fruits of Garcinia mangos-
tana) was provided by Sunrider International (CA, USA)
and employed as dietary treatment. The nutritional infor-
mation of the supplement is shown in Table 1. To deter-
mine the total polyphenolic content, CCGG was extracted
using a solvent in a 4:6 ratio of methanol and water (v/v)
with 0.5 % hydrochloric acid. Aliquots of a 50-μL solution
containing extract or a standard solution of gallic acid
were mixed with 1 mL of a 2 % w/v sodium carbonate so-
lution and allowed to stand for 2 min with intermittent
shaking. Subsequently, 50 μL of 50 % v/v Folin–Ciocalteu
reagent (Sigma-Aldrich, St. Louis, MO, USA) was added
and incubated for 10 min in the dark. Absorbance was
spectrophotometrically read at 750 nm. To determine
epigallocatechin gallate (EGCG) and α-mangostin, a high-
performance liquid chromatograph (HPLC; Hitachi,
Tokyo, Japan) equipped with a LiChroCART 250-4,6 col-
umn, ultraviolet-visible spectroscopy L-2420 detector, L-
2200 autosampler and L-2130 pump was used. The HPLC
conditions for analysing EGCG and α-mangostin were
slightly modified from those described in previous studies
[28, 29]. All of the analyses were performed adequately in
three replicates. The total polyphenol, EGCG and α-
mangostin contents in CCGG were 196 mg/g, 4.0 mg/g
and 1.5 mg/g, respectively.
An animal diet was LabDiet 5001 rodent diet (LabDiet,
St. Louis, MO, USA) in a vehicle control group (vehicle),
and an additional 0.2 % cholesterol and 10 % lard were
added to the diet for a high-cholesterol diet group
(HCD).
Animals and treatment
The animal use protocol was submitted to and had been
approved by the Institutional Animal Care and Use
Committee (IACUC) of National Taiwan Sport Univer-
sity (Taoyuan, Taiwan). The IACUC approval number of
the present study was IACUC-10210 and was valid from
10/20/2013 to 12/31/2014. We declared all animal ex-
periments were conducted according to the protocol.
Table 1 The nutritional information of CCGG
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Male golden Syrian hamsters (4 weeks old) were pur-
chased from the National Laboratory Animal Center
(Taipei, Taiwan) and maintained in 12 h of light/dark at
a temperature of 24 ± 2 °C and 65 ± 5 % humidity with
access to food and water ad libitum. The hamsters were
monitored daily for food intake. Body weight and water
intake were recorded two times per week. The food effi-
ciency was calculated at the end of the experiments.
After 4 weeks of acclimatisation, the hamsters were ran-
domised into five groups (n = 8 per group): (1) vehicle
control (Vehicle), (2) high-cholesterol diet control
(HCD), (3) high-cholesterol diet with 311 mg/kg/d of
CCGG (CCGG-1X), (4) high-cholesterol diet with
622 mg/kg/d of CCGG (CCGG-2X) and (5) high-
cholesterol diet with 1555 mg/kg/d of CCGG (CCGG-
5X). The hamster CCGG dose (311 mg/kg/d) was con-
verted from a human equivalent dose (HED) based on
body surface area by the following formula from the
US Food and Drug Administration: assuming a human
weight of 60 kg, the HED for 2.5 (g/d) ÷ 60 (kg) =
0.042 × 7.4 = hamster dose of 311 mg/kg/d. The con-
version coefficient 7.4 was used to account for differ-
ences in body surface area between a hamster and a
human. CCGG was dissolved using deionised water
and administered to the hamsters by gastric tube in a
dose of 0.01 mL/g. At the end of week 6, the hamsters
were anaesthetised with 5 % isoflurane at the rate of
0.5 L/min and euthanised by exsanguination after 12 h
of food deprivation. Blood samples were collected
from the abdominal aortas. The hearts, livers, kidneys,
lungs and fat depots (epididymal fat) were collected
and weighed. Serum samples were isolated using cen-
trifugation at 2000 × g for 15 min. All of the samples
were snap-frozen and stored at -80 °C until further
analysis.
Biochemical analysis of serum samples
The biochemical parameters, including aspartate amino-
transferase (AST), alanine transaminase (ALT), alkaline
phosphatase (Alk-P), lactate dehydrogenase (LDH), cre-
atine phosphokinase (CPK), albumin, total bilirubin,
total protein (TP), blood urea nitrogen (BUN), creatin-
ine, uric acid (UA) and glucose, were analysed. Blood
lipid parameters, including total cholesterol (TC), tri-
glycerides (TG), low-density lipoprotein cholesterol
(LDL-C) and high-density lipoprotein cholesterol (HDL-
C), were measured using an autoanalyser (Hitachi,
Tokyo, Japan). An adiponectin ELISA kit (Assaypro, St.
Charles, MO, USA), insulin ELISA kit (BlueGene,
Shanghai, China), TNF-α ELISA kit (Randox, Antrim,
UK) and IL-6 ELISA kit (Cusabio, Hubei, China) were
used according to the manufacturer’s protocols to deter-
mine the serum levels of adiponectin, insulin, TNF-α,
and IL-6. The homeostasis model assessment of insulin
resistance (HOMA-IR) was then calculated according to
the homeostasis of the assessment by using the following
equation [30]:
HOMA−IR ¼ glucose mmol=Lð Þ  insulin μL U=mLð Þ½  = 22:51
Liver lipid content
To determine liver cholesterol and triglycerides, 20 mg
of liver tissue was homogenised in a 200-μL solvent
(chloroform:isopropanol:NP40 = 7:11:0.1). Centrifuged at
12 000 × g for 10 min, an aliquot of 100 μL was ex-
tracted and dried. The pellet was reconstituted with a
buffer (1 M of potassium phosphate, pH = 7.4, 500 mM
of sodium chloride, 50 mM of cholic acid), and water
bath sonication was employed to dissolve the precipitate.
A Cholesterol Fluorometric Assay Kit (Cayman, Ann
Arbor, MI, USA) and Triglyceride Colorimetric Assay
Kit (Cayman, Ann Arbor, MI, USA) were used to analyse
liver cholesterol and triglyceride contents.
Faecal lipid content
Faeces were collected and dried in an oven at Week 6.
Subsequently, 0.1 g of faeces were pulverised in 1 mL
of phosphate buffered saline and extracted using a solv-
ent (chloroform:methanol = 2:1). The organic phase was
filtered using filter paper (Whatman NO.5). Afterwards,
the residue was dried and reconstituted with 1 mL of
dimethyl sulphoxide. Water bath sonication was used
to dissolve the precipitate. A cholesterol liquid assay
(Randox, Antrim, UK), Triglyceride Colorimetric Assay
Kit (Cayman, Ann Arbor, MI, USA) and Total Bile
Acids Assay Kit (Crystal Chem, Downers Grove, IL,
USA) were adopted to analyse faecal cholesterol, trigly-
ceride and bile acid contents.
Histopathology of tissues
Liver, fat, heart, kidney and lung tissues were removed
at the end of the experiment, fixed in 10 % buffered
formalin, and then embedded in paraffin. The paraffin-
embedded samples were sectioned and underwent
haematoxylin and eosin (H&E) staining under a light
microscope equipped with a charge-coupled device
camera (Olympus, Tokyo, Japan) by a clinical pathologist.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). One-way ANOVA with Tukey’s posttest and
Pearson correlation for dose-dependent effect were used
for all data comparisons. A P < 0.05 was statistically sig-
nificant. Statistical analyses were conducted using the
SPSS 19.0.
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Results
Effects of CCGG supplementation on body weight, organ
weight, and diet intake
After CCGG treatment in the hamsters, significant differ-
ences in body weight were observed between the CCGG-
5X and HCD groups from Week 3 (Fig. 1). The body
weight of the CCGG-1X and CCGG-2X groups were
slightly nonsignificantly lower than that of the HCD
group. The average final body weight of the CCGG-5X
group decreased significantly by 15.9 % (P < 0.01) com-
pared with the HCD group without affecting food and
water intake (Table. 2). Furthermore, the CCGG-supple
mentation yielded a low food efficiency ratio. In addition,
tissue weights were measured at the end of the study
(Fig. 2). The weights of the liver, epididymal fat and heart
tissues decreased significantly in the CCGG-5X group (by
23.4 %, 41.4 % and 14.4 %, respectively) compared with
the HCD group. No significant change was observed in the
weight of the kidney and lung among the groups (P > 0.05
vs. the HCD group).
Effects of CCGG supplementation on serum lipid profiles
An HCD diet fed to the hamsters significantly in-
creased the serum levels of TG, TC, HDL-C and LDL-
C by 245.6 %, 142.6 %, 57.5 % and 174.1 %, respectively
(P < 0.001 vs. the vehicle group) (Fig. 3). After the
CCGG supplementation, the treated groups exhibited
a significant decrease in the serum levels of TG
(61.3 %, 58.7 % and 67.6 % reduction in the CCGG-1X,
CCGG-2X and CCGG-5X groups, respectively), TC
(27.4 %, 33.3 % and 41.8 % reduction in the CCGG-1X,
CCGG-2X and CCGG-5X groups, respectively), and
LDL-C (38.0 %, 54.3 % and 65.7 % reduction in the
CCGG-1X, CCGG-2X and CCGG-5X groups, respect-
ively) compared with the HCD group. Strongly dose-
dependent effects were observed in the serum levels of
TC (r = -0.729, P < 0.001) and LDL-C (r = -0.676, P < 0.001).
No significant changes were found in the HDL-C between
the HCD group and treated groups. Furthermore, no
significant differences in serum adiponectin levels were
observed among the groups (Table 3).
Effects of CCGG supplementation on serum glycaemic
markers and insulin resistance
Glucose and insulin levels were measured after 6 weeks
of CCGG treatment. A high-cholesterol diet increased
glucose and insulin levels by 18.6 % (P = 0.21 vs. the
vehicle group) and 27.7 % (P < 0.05 vs. the vehicle
group), respectively. Insulin levels decreased in CCGG-
supplemented groups by 17.4 %–27.7 %, compared with
the HCD group (Fig. 4 (a)); however, glucose levels
showed no significant change (Table 3). In addition, the
HOMA-IR levels in the CCGG-supplemented groups
were markedly improved by 33.8 %–42.3 %, compared
with the HCD group (Fig. 4 (b)).
Effects of CCGG supplementation on serum cytokine
levels
Regarding serum proinflammatory cytokine levels, we
determined an increase in TNF-α by 44.9 % in the HCD
group, compared with the vehicle group (P < 0.001).
However, no differences (P = 0.16) in IL-6 were observed
between the vehicle and HCD groups (Fig. 5). Supple-
mentation with CCGG reduced serum TNF-α by
27.4 %–32.3 % versus the HCD group (P < 0.001). In
addition, a reduction of 29.6 % in serum IL-6 was ob-
served in the CCGG-5X group, versus the HCD group
(P < 0.05).

























Fig. 1 Body weights over the course of 6 weeks. Values are expressed as mean ± SEM. Body weights of each group were compared by one-way
ANOVA with Tukey’s posttest. (* P < 0.05, ** P < 0.01 compared with HCD). Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X;
high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with 622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet with
1555 mg/kg/d of CCGG
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Effects of CCGG supplementation on serum biochemical
parameters
The safety of consuming CCGG was monitored at the
end of the study. As shown in Table 3, no significant
changes in total protein among the groups were ob-
served compared with the HCD group. As indicators of
hepatotoxicity, AST, ALT, Alk-P, albumin, total bilirubin
and TP showed no differences among the groups versus
the HCD group (P > 0.05). As indicators of nephrotox-
icity, UA and creatinine showed no differences among
the groups versus the HCD group (P > 0.05), whereas
BUN was lower in the HCD group than in the four other
groups. Similarly, as an indicator of cytotoxicity, LDH
showed no differences among the groups versus the
HCD group (P > 0.05). However, for CPK, an attenuation
by 55.8 % in the CCGG-5X group, compared with the
HCD group, was observed (P < 0.05).
Effects of CCGG supplementation on hepatic and faecal
lipid contents
Table 4 presents the results for hepatic and faecal lipid
contents. In the liver, TG and cholesterol levels in-
creased by 162.4 % and 547.2 %, respectively, in the
HCD group compared with the vehicle group. CCGG
supplementation significantly decreased TG levels
(46.5 %, 46.0 % and 44.2 % in the CCGG-1X, CCGG-2X
and CCGG-5X groups, respectively) and cholesterol
levels (35.6 %, 50.2 % and 64.8 % in the CCGG-1X,
CCGG-2X and CCGG-5X groups, respectively) com-
pared with the HCD group. A dose-dependent effect was
observed in hepatic cholesterol levels (r = -0.625, P < 0.001).
In the faeces, TG, cholesterol and bile acid levels were in-
creased by 27.5 %, 51.5 % and 83.2 % in the HCD group,
compared with the vehicle group. However, no significant
change was observed in the faecal TG in each of the
groups, compared with the HCD group. Moreover, a de-
crease in faecal cholesterol was found in the CCGG-2X
group, but not in the CCGG-1X or CCGG-5X groups,
compared with the HCD group. Cholesterol tended to bind
with bile and present as bile acid observed in the faeces.
Supplementation increased the excretion of bile acid
(37.1 %, 36.6 % and 30.1 % in the CCGG-1X, CCGG-2X
and CCGG-5X groups, respectively), compared with the
HCD group.
Effect of CCGG supplementation on the histopathology of
tissues
The major organs, including the liver, epididymal fat,
heart, kidney and lung, were examined. As shown in
Fig. 6, histological analysis of the liver tissues revealed
abundant foamy cells in the HCD group. In CCGG-
supplemented groups, the inner area of the circle close
to central vein presented foamy cells while the outer
area presented relatively normal cells. CCGG brought
inhibitory effects on formation of foamy cells extended
from hepatic portal vein to central vein. In addition,
the groups did not differ in histological observations
of the epididymal fat, heart, kidney and lung tissues
(see Additional file 1).
Table 2 Final body weight and effects of CCGG supplementation on food intake, water intake and food efficiency ratio
Vehicle HCD CCGG-1X CCGG-2X CCGG-5X
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Final body weight (g/hamster) 120.4 2.0 130.6 4.2 120.7 3.7 120.5 3.7 109.9** 2.8
Food intake (g/hamster/week) 71.8 6.9 68.5 6.0 66.0 6.5 76.1 9.6 80.6 9.0
Water intake (g/hamster/week) 78.8** 4.2 60.6 3.8 62.1 3.0 59.4 3.3 51.6 2.7
Food efficiency ratio (%) 4.2 0.8 5.4 0.9 4.7 0.9 3.9 1.1 1.2* 0.6
Values are expressed as mean ± SEM. Statistical significance was determined using the one-way ANOVA with Tukey’s posttest
*P < 0.05, **P < 0.01 compared with HCD
Food efficiency ratio = Body weight gain (g)/Food intake (g)
Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X; high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with








































Fig. 2 Tissue weights at the end of the experiment. Values are
expressed as mean ± SEM. Statistical significance was determined
using the one-way ANOVA with Tukey’s posttest. **P < 0.01,
***P < 0.001 compared with HCD. Vehicle; vehicle control, HCD;
high-cholesterol diet control, CCGG-1X; high-cholesterol diet with
311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with
622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet with
1555 mg/kg/d of CCGG
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Discussion
Dyslipidaemia is characterised by an increase in total
cholesterol, low-density lipoprotein cholesterol, triglycer-
ides or a combination of these abnormalities. The even-
tual clinical outcomes may include angina, myocardial
infarction, arrhythmias, stroke, peripheral arterial dis-
ease, abdominal aortic aneurysm and sudden death [3].
Dyslipidaemia is one of the most severe metabolic dis-
eases and a real problem currently encountered in the
world. Instead of taking medicine, supplementation may
be another approach to amelioration this chronic condi-
tion. In this study, we used golden Syrian hamsters fed a
high-cholesterol diet (0.2 % cholesterol) and added an
additional 10 % lard for our model. The animal model
was shown to be appropriate because the major features
of a lipid metabolism and atherosclerosis were similar
between hamsters and human beings [24, 25]. This study
was designed to investigate the beneficial effects of a
CCGG supplement on lipid profiles, glycaemic markers,
proinflammatory cytokines and related toxicity markers.
Regarding cocoa, Khan et al. [31] evaluated the effects
of chronic cocoa consumption on the lipid profiles of
volunteers exhibiting a high risk of cardiovascular dis-
ease. After 4 weeks, HDL-C levels were higher compared
with TC, TG and LDL-C levels. In addition, the LDL/
HDL-C ratio showed no significant change. However, Jia
et al. [13] examined the short-term effect of cocoa prod-
uct consumption on the lipid profiles of eight trials.
LDL-C and TC levels were lowered, but no change in
HDL-C was observed. No evidence for a dose-response
effect was obtained. Regarding coffee, the effect of coffee
on blood lipids remains controversial. Panchal et al. [32]
revealed that coffee extract supplementation for 8 weeks
could not change the abdominal obesity or dyslipidaemia
in high-carbohydrate, high-fat rats. A meta-analysis con-
ducted by Cai et al. [33] suggested that the serum levels
of TC, LDL-C and TG may significantly increase in
Western people who consume coffee daily. By contrast,
a single-dose of coffee polyphenols could drastically
modulate postprandial hyperlipidaemia in mice [34]. The
effects of coffee beans are subsequently related to its
phenol, oil and caffeine contents. Regarding green tea,
the most effective polyphenol compounds against dysli-



































































































































Fig. 3 Effects of CCGG supplementation on serum lipids. a; serum triglycerides levels. b; serum total cholesterol levels. c; serum high-density lipoprotein
cholesterol. d; serum low-density lipoprotein cholesterol. Values are expressed as mean ± SEM. Statistical significance was determined using the one-way
ANOVA with Tukey’s posttest. **P< 0.01, ***P< 0.001 compared with HCD. Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X;
high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with 622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet with
1555 mg/kg/d of CCGG
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catechins [10]. Particularly through modulating PPAR
expression, green tea leaf extract was shown to improve
lipid homeostasis by decreasing plasma and hepatic
lipids and increasing serum adiponectin in rodent
models [4, 5]. In addition, relatively few studies have fo-
cused on the benefits of Garcinia mangostana on blood
lipids and have primarily investigated its antioxidant,
antitumoural, antiinflammatory, antiallergy, antibacterial,
antifungal and antiviral properties [11]. Xanthones (e.g.
α-mangostin) are believed to be beneficial compounds.
Nevertheless, Adiputro et al. [17] revealed a significant
decrease in TC, LDL-C and TG as well as an increase in
HDL-C in high-lipid fed rats after consuming mango-
steen extract for 60 d.
We observed body weight and tissue weight. The
liver, epididymal fat and heart were lower in the
CCGG-5X group compared with the HCD group.
These findings suggest that CCGG supplementation
had potential effects on weight loss and organ protec-
tion. In addition, we observed that serum lipid levels
were markedly increased in the HCD-fed hamsters
compared with the normal chow-fed hamsters, and
these increases were ablated by CCGG supplementa-
tion, even reversed to nearly baseline. Notably, simply
dose-dependent reductions appeared in TC and LDL-C
serum levels. Furthermore, hepatic lipid levels were
increased in the HCD group. CCGG supplementation
significantly decreased TG (by approximately 45 %) and
cholesterol (dose-dependent) in the liver. In particular,
hepatic steatosis improvement was observed in the
histopathology. In addition, principally by the increase
in the excretion of bile acid in faeces (by approximately
35 %), the absorption of a cholesterol diet was limited
by CCGG supplementation.
Insulin resistance is a major underlying factor con-
tributing to dyslipidaemia and hepatic steatosis [7].
HOMA-IR was reported to primarily indicate hepatic
insulin resistance [35]. Improved HOMA-IR was revealed
in previous studies after consuming 10-week flavan-3-ols-
rich cocoa powder [12], 11-week 5-caffeoylquinic acid-rich
coffee bean extract [19], and 8-weeks α-mangostin-rich
mangosteen extract [36] in rodent models. However, the
effect of green tea extract on insulin resistance remains
controversial. Even increments in serum glucose and insu-
lin levels were observed after 8-weeks EGCG-rich green
tea extract intervention, leading to the development of dis-
eases such as diabetes [37]. In our study, we determined
that CCGG supplementation significantly decreased serum
insulin levels and ameliorated the HOMA-IR index, but
did not affect fasting blood glucose levels. Similarly, a lack
of blood glucose regulation after treatment with phenolic
compounds in mice, despite a significant reduction in insu-
lin production, was reported [12]. It might take longer time
either to induce or attenuate glucose level.
Inflammation leads to changes in lipid metabolism
aimed at decreasing the harmful agents and promoting
tissue repair involved in host defense [38]. As the adipo-
cytes of individuals enlarge, the adipose tissue undergoes
physiological alterations that subsequently affect sys-
temic metabolism. First, macrophages accumulate within
Table 3 Effects of CCGG supplementation on serum biochemical analysis
Vehicle HCD CCGG-1X CCGG-2X CCGG-5X
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Adiponectin (ng/mL) 33.17 0.74 31.36 0.74 31.65 1.57 36.61 2.70 36.38 1.29
Glucose (mmol/L) 8.64 0.56 10.25 0.53 8.53 0.30 8.19 0.52 8.17 0.58
Albumin (g/dL) 3.40 0.05 3.34 0.06 3.33 0.05 3.23 0.05 3.19 0.05
AST (U/L) 56.5 3.2 46.4 1.8 56.9 3.0 47.1 2.9 45.3 2.6
ALT (U/L) 68.1 2.7 88.3 4.1 82.5 4.9 101.1 10.9 93.8 5.2
Alk-P (U/L) 112.1 3.8 103.3 3.6 115.0 4.0 115.6 3.4 116.4 7.8
Bilirubin (mg/dL) 0.38 0.03 0.34 0.03 0.33 0.04 0.35 0.02 0.35 0.03
TP (g/dL) 5.55 0.08 5.55 0.10 5.48 0.05 5.35 0.10 5.26 0.09
UA (mg/dL) 0.98 0.06 0.85 0.07 1.22 0.18 1.19 0.13 1.15 0.11
Creatinine (mg/dL) 0.18 0.02 0.14 0.01 0.16 0.01 0.13 0.01 0.17 0.01
BUN (mg/dL) 20.21** 0.67 15.89 0.94 19.17* 0.22 19.74** 0.70 19.50** 0.76
LDH (U/L) 176.6 9.9 164.4 8.8 209.5 35.7 150.3 14.0 127.0 8.2
CPK (U/L) 1205.8 137.4 1036.8 198.4 923.0 126.6 553.3 93.1 458.0* 83.9
Values are expressed as mean ± SEM. Statistical significance was determined using the one-way ANOVA with Tukey’s posttest
*P < 0.05, **P < 0.01 compared with HCD
Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X; high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with
622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet with 1555 mg/kg/d of CCGG
AST; aspartate aminotransferase, ALT; alanine transaminase, Alk-P; alkaline phosphatase, LDH; lactate dehydrogenase, CPK; creatine phosphokinase, BUN; blood
urea nitrogen, UA; uric acid, TP; total protein
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adipose tissue, leading to local inflammation. Several
proinflammatory factors (including TNF-α and IL-6) are
produced [1, 2]. Importantly, inflammatory cytokines,
which are protagonists in plaque formation throughout
the atherosclerotic vessel, are produced. Therefore,
chronic inflammation is a major contributing factor to
atherosclerotic disease. Regarding cocoa, a previous
study [39] suggested that cocoa rich in flavonoids
has the dose-dependent effects of diminishing TNF-α
and MCP-1. Gu et al. [12] reported that a dietary
proanthocyanidin-rich cocoa supplement decreased
plasma IL-6 and MCP-1 instead of TNF-α. Regarding cof-
fee, Yamauchi et al. investigated 5-weeks coffee and caf-
feine consumption in diabetic KK-Ay mice. Inflammatory
markers of serum IL-6 were improved, but not monocyte
chemoattractant protein-1 (MCP-1) [40]. However, a
cross-sectional study revealed that coffee consumption
does not affect serum TNF-α and IL-6 in Japanese
workers [41]. Similarly, green tea has the potential effect
of preventing inflammation by inhibiting MCP-1 [42] and
TNF-α [43] expression. Regarding garcinia, α-mangostin
plays a crucial role in antiinflammation. Both in vitro
and in vivo studies have indicated the beneficial effects
of suppressing the production of TNF-α [44, 45].
In our study, the results showed that serum TNF-α
levels, but not IL-6, were increased in the HCD-fed
hamsters. However, after the 6-weeks CCGG treatment,































































Fig. 4 Effects of CCGG supplementation on glycemic markers. a;
serum insulin levels. b; HOMA-IR index. Values are expressed as mean
± SEM. Statistical significance was determined using the one-way
ANOVA with Tukey’s posttest. *P < 0.05, **P < 0.01, ***P < 0.001
compared with HCD. Vehicle; vehicle control, HCD; high-cholesterol
diet control, CCGG-1X; high-cholesterol diet with 311 mg/kg/d of
CCGG, CCGG-2X; high-cholesterol diet with 622 mg/kg/d of CCGG,


































































Fig. 5 Effects of CCGG supplementation on pro-inflammatory cytokines.
a; serum tumor necrosis factor-alpha levels. b; serum interleukin-6 levels.
Values are expressed as mean ± SEM. Statistical significance was
determined using the one-way ANOVA with Tukey’s posttest. *P < 0.05,
***P < 0.001 compared with HCD. Vehicle; vehicle control, HCD;
high-cholesterol diet control, CCGG-1X; high-cholesterol diet with
311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with 622 mg/kg/
d of CCGG, CCGG-5X; high-cholesterol diet with 1555 mg/kg/d of CCGG
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three different-dosage-treated groups with a similar
effect (approximately 30 % reduction). Furthermore,
adiponectin is a secreted serum protein expressed
exclusively in differentiated adipocytes. Adiponectin was
shown to be highly correlated with metabolic syndrome
and cardiovascular disease [46]. Adiponectin regulation
is coordinated by other factors, including body mass
index and serum TG [47]. A recent study [48] reported
no change in serum adiponectin levels in 4-mo high-fat
diet-induced obese rats. Thus, adiponectin levels might
possibly be affected by some cooperative interaction
because no differences occurred in serum adiponectin in
our five groups. In addition, we observed that the CCGG
supplement doses showed no sign of toxicity towards
biochemical markers or histopathology and did not
affect food or water intake.
On the whole, in CCGG, there were strong evidences
that dyslipidaemia mediated by cocoa and green tea; insu-
lin resistance mediated by cocoa, coffee and garcinia;
inflammation mediated by cocoa, coffee, green tea and
garcinia. Therefore, contributed by combined ingredients,
we proposed that CCGG might exert a synergic effect.
Accordingly, whether the combined ingredients indeed
enhance the benefit and reduce the effective dose was
crucial, since some studies [49–51] revealed their out-
comes with disappointment after supplementation with
multi-ingredient. However, our results are satisfactory.
Based on conversion of animal doses to human equiva-
lent doses from the US Food and Drug Administration,
the doses of CCGG supplementation in hamster which
are equivalent to 42, 84 and 210 mg/kg/d in human.
Compared to single ingredient, less dose of CCGG sup-
plementation might also be effective. Gu et al. [12] in-
vestigated the effect of cocoa powder supplementation
on obesity-related inflammation in high fat fed obese
mice. A 10-week 8 % unsweetened cocoa powder (approxi-
mately equivalent to 465 mg/kg/d in human) ameliorated
obesity-related inflammation, insulin resistance and fatty
liver disease. Panchal et al. [32] characterized the effects of
coffee extract on a rat model of human metabolic syn-
drome. An 8-weeks 5 % aqueous coffee extract (approxi-
mately equivalent to 294 mg/kg/d in human) attenuated
hypertension and impairment in glucose homeostasis with-
out affecting abdominal fat deposition and plasma lipid
profile. Luo et al. [4] investigated the effects of dietary sup-
plementation with green tea on cholesterol and circulating
immune complexes in SD rats fed with a high-cholesterol
diet. A 30-d leaf powder of dose 1.0 or 2.0 g/kg body
weight (approximately equivalent to 161 or 323 mg/kg/d in
human) resulted in a significant decrease in plasma TC
levels and circulating immune complexes and an increase
in HDL-C. Adiputro et al. [17] evaluated the effect of man-
gosteen extract on lipid profile in rats fed a high lipid diet.
A 60-d ethanolic extract of Garcinia mangostana pericarp
Table 4 Effects of CCGG supplementation on hepatic and faecal lipids
Vehicle HCD CCGG-1X CCGG-2X CCGG-5X
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
Liver (mg/g)
TG 142.3*** 17.1 373.4 27.6 199.8*** 21.6 201.8*** 24.4 208.5*** 23.0
Cholesterol 0.36*** 0.02 2.33 0.38 1.50* 0.13 1.16** 0.12 0.82*** 0.62
Faeces (mg/g)
TG 21.8 2.1 27.8 2.2 37.6 3.8 37.3 1.9 17.8 2.1
Cholesterol 1.63*** 0.05 2.47 0.09 2.38 0.70 1.97** 0.79 2.21 0.13
Bile acid 3.74** 0.26 6.85 0.46 9.39* 0.71 9.36* 0.32 8.91 0.67
Values are expressed as mean ± SEM. Statistical significance was determined using the one-way ANOVA with Tukey’s posttest
*P < 0.05, **P < 0.01, ***P < 0.001 compared with HCD
Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X; high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with
622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet with 1555 mg/kg/d of CCGG
TG; triglycerides
Fig. 6 Histopathology of liver tissues. (H & E stain, magnification: 200×, Scale bar: 40 μm). Vehicle; vehicle control, HCD; high-cholesterol diet control,
CCGG-1X; high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X; high-cholesterol diet with 622 mg/kg/d of CCGG, CCGG-5X; high-cholesterol diet
with 1555 mg/kg/d of CCGG
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at dosages of 400 or 800 mg/kg body weight (approxi-
mately equivalent to 65 or 129 mg/kg/d in human)
significantly decreased cholesterol, TG and LDL-C levels.
Concerning our results showed effective dose started at
CCGG-1X group (equivalent to 42 mg/kg/d in human).
Therefore, compared to previous studies focusing on single
ingredient, the CCGG might have the synergic beneficial
effects with relatively lower dose consumption. However,
our limitation is that we cannot directly compare the
effects of CCGG with each single ingredient. Additional
studies are also required to assess the underlying mechan-
ism that mediates the synergic effects of CCGG.
Conclusion
In conclusion, we demonstrated hypolipidaemic effects
of a 6-weeks dietary supplementation by using a com-
bined extract (consisting of CCGG) in HCD-fed ham-
sters. CCGG markedly attenuated serum lipid profiles
(TG, TC, and LDL-C) and hepatic lipid profiles (TG and
cholesterol) with dose-dependent effects, and increased
faecal bile acid content. Furthermore, HOMA-IR index
and serum cytokine levels (IL-6 and TNF-α) involved in
dyslipidaemia were improved, and no toxicity appeared.
Thus, we propose that CCGG may have potential effects
of ameliorating hyperlipidaemia, insulin resistance, liver
steatosis and related inflammation.
Additional file
Additional file 1: Histopathology of epididymal fat, kidney, heart
and lung tissues. a; epididymal fat tissue. b; kidney tissue. c; heart
tissue. d; lung tissue. (H & E stain, magnification: 200×, Scale bar: 40 μm).
Vehicle; vehicle control, HCD; high-cholesterol diet control, CCGG-1X;
high-cholesterol diet with 311 mg/kg/d of CCGG, CCGG-2X;
high-cholesterol diet with 622 mg/kg/d of CCGG, CCGG-5X;
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